Drugs in Development
Focus on AASLD 2007: Nov 8 2007
Drugs in Development
by Alan Franciscus,
Editor-in-Chief, HCV Advocate
Having just returned from the American Association for the Study of Liver
Diseases (AASLD) conference I was struck by how much information was
released about new drugs in development to treat hepatitis C.
This is a very hopeful and exciting era in the HCV drug development process.
This article is a brief overview of the data about experimental HCV
therapies that was released at the recent AASLD conference.
More detailed information about some of these drugs will be available in the
December issue of the HCV Advocate newsletter.
Click here to view the remainder of the article.
* w w w .hcvadvocate.org/hepatitis/hepC/Focus%20on%20AASLD%202007-Drugs%20in%20Development.html